International Barrier Technology -- Fire-Resistant Building

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
International Barrier Technology -- Fire-Resistant Building Materials Company -- Reports Fiscal Year Revenue of $5,995,010 and Record Sales Volume of 13,243,741 sq. ft. for YE June 30, 2013

WATKINS, MN--(Marketwired - Jul 25, 2013) - International Barrier Technology Inc. ("Barrier") ( OTCBB : IBTGF ) ( TSX VENTURE : IBH ), a manufacturer of proprietary fire-resistant building materials, is pleased to report record sales volumes for the month, the quarter and the fiscal year ending June 30, 2013. 

Record monthly shipments of 1,873,112 sq. ft. were realized during the month of June, a 151% increase over the 747,700 sq. ft. shipped in June 2012. Record Q4 shipments were achieved as 5,161,600 sq. ft. shipped Apr-Jun 2013 a 104% increase in comparison to 2,531,100 sq. ft. during the same quarterly period last year. Residential Roof Deck/Wall Assembly/Structural Insulated Panel markets represented 70% and the Commercial Modular market represented 30% of total quarterly shipments. 

Record sales volume of 13,243,741 sq. ft. was shipped for the fiscal year ending June 30, 2013. This was an increase of 37% from the 9,687,029 sq. ft. shipped in Fiscal 2012. Residential Roof Deck/Wall Assembly/Structural Insulated Panel market business grew by 51% year over year and represented 71% of total Barrier shipments. The Commercial Modular market was up 11% year over year and represented 29% of total shipments. 

Monthly sales revenue grew 142%; quarterly sales revenue increased 136%; and fiscal year sales revenue for the period ending June 30, 2013 was up 45% from $4,144,806 to $5,995,010 over the comparable periods last year. Fiscal year revenue generated from Residential Roof Deck/Wall Assembly/Structural Insulated Panel markets rose 54% and revenue from the Commercial Modular market inclined 7%.

"Barrier is pleased by our overall improvement in sales volume as measured by both product shipped and revenue," reports Dr. Michael Huddy, Barrier CEO and Director. "The majority of our increases in year to year business occurred in the final six months of the fiscal year ending June 30, 2013. We expect to see continued growth over the next six months as fire-rated wall assemblies utilizing our proprietary technology gain increasing attention and acceptance within the building community."

About International Barrier Technology Inc. International Barrier Technology Inc. ( OTCBB : IBTGF ) ( TSX VENTURE : IBH ) develops, manufactures, and markets proprietary fire-resistant building materials branded as LP ® FlameBlock ® Fire-Rated OSB Sheathing and Mule-Hide FR Deck Panel. Barrier's award-winning fire-resistant wood panels use a patented, non-toxic, non-combustible coating with an extraordinary capability: it releases water in the heat of fire. The panels exceed "model" building code requirements in every targeted fire test and application, and are unique in combining properties that increase panel strength and minimize environmental and human impact. Barrier's family of products provides customers a premium material choice meeting an increasingly challenging combination of requirements in residential and commercial building construction. For more information please visit: www.intlbarrier.com .

INTERNATIONAL BARRIER TECHNOLOGY INC.

______________________ Michael D. Huddy President, Director

THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS PRESS RELEASE.

Melissa McElwee CFO International Barrier Technology (800) 638-4570 Email Contact For more information please visit: www.intlbarrier.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading